IRVINE, Calif., Oct. 9, 2019 /PRNewswire/ -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in patient-focused
innovations for structural heart disease and critical care
monitoring, plans to announce its operating results for the quarter
ended September 30, 2019 after the
market closes on Wednesday, October 23,
2019, and will host a conference call at 5:00 p.m. ET that day to discuss those
results.
To participate in the conference call, dial (877) 704-2848 or
(201) 389-0893. For 72 hours following the call, an audio replay
can be accessed by dialing (877) 660-6853 or (201) 612-7415 and
using conference number 13694541. The call will also be available
via live or archived webcast on the "Investor Relations" section of
the Edwards web site at ir.edwards.com.
About Edwards Lifesciences
Edwards Lifesciences, based
in Irvine, Calif., is the global
leader in patient-focused medical innovations for structural heart
disease, as well as critical care and surgical monitoring. Driven
by a passion to help patients, the company collaborates with the
world's leading clinicians and researchers to address unmet
healthcare needs, working to improve patient outcomes and enhance
lives. For more information, visit www.Edwards.com and follow us on
Twitter @EdwardsLifesci.
Edwards is a trademark of Edwards Lifesciences Corporation.
Edwards Lifesciences and the stylized E logo are trademarks of
Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark
Office.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-host-earnings-conference-call-on-october-23-2019-300934265.html
SOURCE Edwards Lifesciences Corporation